12:00 AM
 | 
Mar 30, 2009
 |  BC Week In Review  |  Clinical News  |  Regulatory

Myfortic mycophenolic acid regulatory update

Novartis introduced a medication guide for Myfortic mycophenolic acid that was developed in conjunction with FDA to provide existing safety information to patients in an...

Read the full 105 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >